Simple Clinical Colitis Activity Index (SCCAI) and future patient-centered telemedical care of Ulcerative Colitis patients
Main Article Content
Abstract
Ulcerative Colitis (UC) is a chronic inflammatory disease of the colon of increasing prevalence characterised by periods of remission and activity. Compared to Crohn’s Disease (CD) symptom-based disease activity indices correlate fairly well with endoscopic and biometric grading of activity 1, 2, 3, 4
We review the mounting number of studies that show that the “Simple Clinical Colitis Activity Index” (SCCAI), originally developed as a physician-completed tool, is the most robust disease activity index when completed by the patient themselves5. With the expansion of telemedicine there is increasing evidence to support novel the use of web-based applications to improve outcomes in UC6. An example of this is the mobile-phone application “IBDSmartTM”, which is currently being piloted in Auckland, New Zealand7.
Article Details
How to Cite
WALMSLEY, Russell; ROY, Ovishek.
Simple Clinical Colitis Activity Index (SCCAI) and future patient-centered telemedical care of Ulcerative Colitis patients.
Medical Research Archives, [S.l.], v. 5, n. 7, july 2017.
ISSN 2375-1924.
Available at: <https://esmed.org/MRA/mra/article/view/1400>. Date accessed: 23 nov. 2024.
Keywords
inflammatory Bowel Disease; ulcerative colitis; simple colitis activity index
Section
Review Articles
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
1. Taleban S, Stewart KO, Li KD, Singh P, et al. Clinical activity and quality of life indices are valid across ulcerative colitis but not Crohn’s disease phenotypes. Dig Dis Sci. 2016; 61:2627-2635
2. Walmsley RS, Ayres RCS, Pounder RE, Allan RN. A simple clinical colitis activity index. Gut. 1998; 43; 29-32
3. Baron JH, Connell AM, Lennard-Jones JE. Variation between observers in describing mucosal appearances in proctocolitis. BMJ. 1964;1:89-92
4. Seo M, Okado M, Yao T, et al. AN index of disease activity in patients with ulcerative colitis. Am J Gastroenterol. 1992:87:971-6
5. Marin-Jimenez I, Nos P, Domenech E, et al. Diagnostic performance of the simple clinical colitis activity index self-administered online at home by patients with ulcerative colitis: CRONICA-UC study. Am J Gastroenterol. 2016; 10.1038/ajg.2015.403
6. Pederson N, et al. Ehealth monitoring in IBS patients treated with low fermentable oligo-, di-, monosaccahrides and polyols diet. World J Gastroenterol. 2014 June 7; 20 (21): 6680-6684
7. Holger R, et al. Field test of a questionnaire-based mobile health reporting system. Proceedings of ACM OzCHI. 2014; 384-387
8. Powell-Tuck J, Brown RL, Lennard-Jones JE. A comparison of oral prednisolone given as a single or multipledaily doses for active proctocolitis. Scand J Gastroenterol. 1978; 13:833-7
9. Jowett SL, Barton JR, Welfare MR. Use of the simple clinical colitis activity index (SCCAI) to define relapse of ulcerative colitis (UC). Gut. 2001; 48 (Suppl I): A1-A124
10. Theede K, Kiszka-Kanowitz M, Nielsen AM, Nordgaard-Lassen I. The correlation between fecal calprotectin, simple clinical colitis activity index and biochemical markers in ulcerative colitis during high-dose steroid treatment. Scan J Gastrenterol. 2014; 49:418-423
11. Higgins PD, Schwartz M, Mapili J, et al. Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis. Clin Gastroenterol Hepatol. 2009; 7:1081-1088
12. Turner D, Seow CH, Greenberg GR, et al. A systematic prospective comparison of noninvasive disease activity indices in ulcerative colitis. Clin Gastroenterol Hepatol. 2009; 7:1081-1088
13. Bewtra M, Brensinger CM, Tomov VT, et al. An optimized patient-reported ulcerative colitis disease activity measure derived from the Mayo score and the Simple clinical colitis activity index. Inflamm Bowel Dis. 2014; 20(6): 1070-1078
14. Lewis JD, Chuai S, Nessel L, et al. Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm Bowel Dis. 2008; 14: 1660-1666
15. Gomes P, Du Boulay C, Smith CL, Holdstock G. Relationshio between disease activity indices and colonic findings in patients with colonic inflammatory bowel disease. Gut. 1986; 27: 92-95
16. Pagnini C, Menasci F, Festa S, et al. Application of clinical indexes in ulcerative colitis patients in regular follow-up visit: correlation with endoscopic ‘mucosal healing’ and implication for management. Preliminary results. Eur Rev Med Pharmacol Sci. 2015; 19: 3674-3681
17. European Commission. The eHealth Network Available at http://ec.europa.eu/health/ehealth/policy/index_en.htm. Accessed on 20 February 2017
18. Pederson N, Thielsen P, Martinsen L, Munkholm P, et al. eHealth: Individualization of Mesalazine treatment through a self-managed web-based solution in mild-to-moderate ulcerative colitis. Inflamm Bowel Dis. 2014; 20: 2276-2285
19. Long DM, Kappelman MD, Martin CF, et al. Development of an internet-based cohort of patients with inflammatory bowel disease (CCFA Partners): Methodology and initial results. Inflamm Bowel Dis. 2012; 18: 2099-2106
20. Aguas Peris M, Del Hoyo J, Bebia P, et al. Telemedicine in inflammatory bowel disease: opportunities and approaches. Inflamm Bowel Dis. 2015; 21: 392-9
21. Elkjaer M, Shuhaibar M, Burisch J, et al. E-Health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided ‘constant-care’ approach. Gut. 2010; 59: 1652-61
22. Stoyanov SR, Hides L, Kavanagh DJ, et al. Mobile app rating scale: A new tool for assessing the quality of health mobile apps. JMIR Health UHealth. 2015; 3(1): e27
23. LoPresti M, Abraham M, Appelboom G, et al. Clinical trials using mobile health applications. Pharm Med. 2015; 29(1): 17-25
24. Semple JL, Sharpe S, Murnaghan ML, et al. Using a mobie app for monitoring post-operative quality of recovery of patients at home: a feasibility study. JMIR MHealth UHealth. 2015; 3(1): e18
25. McCombie A, Langlotz T, Barclay M, et al. Systematic review of IBD smartphone apps for symptom monitoring and communication with healthcare professionals. Journal MHealth. 2016; 36-40
26. https://www.guthealthnetwork.com/tools-and-links/ibdsmart/
27. Dudley-Brown S. Correlates of uncertainty in inflammatory bowel disease. Dissertation abstracts international UMI no. 9604387. 1995
28. Thia K, Faubion WA Jr, Loftus EV Jr, Persson T, Persson A, Sandborn. Short CDAI: development and validation of a shortened and simplified Crohn’s disease activity index. Inflamm Bowel Dis. 2011; 17 (1): 105-11. doi: 10. 1002/ibd.21400
29. Harvey RF, Bradshaw JM. A simple index of Crohn’s disease activity. Lancet. 1980; 1: 514
30. McCombie A, et al. IBDSmartTM trial. HDEC 15/NTA/44. The Australian New Zealand Clinical Trials Registry. ACTRN12615000342516
2. Walmsley RS, Ayres RCS, Pounder RE, Allan RN. A simple clinical colitis activity index. Gut. 1998; 43; 29-32
3. Baron JH, Connell AM, Lennard-Jones JE. Variation between observers in describing mucosal appearances in proctocolitis. BMJ. 1964;1:89-92
4. Seo M, Okado M, Yao T, et al. AN index of disease activity in patients with ulcerative colitis. Am J Gastroenterol. 1992:87:971-6
5. Marin-Jimenez I, Nos P, Domenech E, et al. Diagnostic performance of the simple clinical colitis activity index self-administered online at home by patients with ulcerative colitis: CRONICA-UC study. Am J Gastroenterol. 2016; 10.1038/ajg.2015.403
6. Pederson N, et al. Ehealth monitoring in IBS patients treated with low fermentable oligo-, di-, monosaccahrides and polyols diet. World J Gastroenterol. 2014 June 7; 20 (21): 6680-6684
7. Holger R, et al. Field test of a questionnaire-based mobile health reporting system. Proceedings of ACM OzCHI. 2014; 384-387
8. Powell-Tuck J, Brown RL, Lennard-Jones JE. A comparison of oral prednisolone given as a single or multipledaily doses for active proctocolitis. Scand J Gastroenterol. 1978; 13:833-7
9. Jowett SL, Barton JR, Welfare MR. Use of the simple clinical colitis activity index (SCCAI) to define relapse of ulcerative colitis (UC). Gut. 2001; 48 (Suppl I): A1-A124
10. Theede K, Kiszka-Kanowitz M, Nielsen AM, Nordgaard-Lassen I. The correlation between fecal calprotectin, simple clinical colitis activity index and biochemical markers in ulcerative colitis during high-dose steroid treatment. Scan J Gastrenterol. 2014; 49:418-423
11. Higgins PD, Schwartz M, Mapili J, et al. Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis. Clin Gastroenterol Hepatol. 2009; 7:1081-1088
12. Turner D, Seow CH, Greenberg GR, et al. A systematic prospective comparison of noninvasive disease activity indices in ulcerative colitis. Clin Gastroenterol Hepatol. 2009; 7:1081-1088
13. Bewtra M, Brensinger CM, Tomov VT, et al. An optimized patient-reported ulcerative colitis disease activity measure derived from the Mayo score and the Simple clinical colitis activity index. Inflamm Bowel Dis. 2014; 20(6): 1070-1078
14. Lewis JD, Chuai S, Nessel L, et al. Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm Bowel Dis. 2008; 14: 1660-1666
15. Gomes P, Du Boulay C, Smith CL, Holdstock G. Relationshio between disease activity indices and colonic findings in patients with colonic inflammatory bowel disease. Gut. 1986; 27: 92-95
16. Pagnini C, Menasci F, Festa S, et al. Application of clinical indexes in ulcerative colitis patients in regular follow-up visit: correlation with endoscopic ‘mucosal healing’ and implication for management. Preliminary results. Eur Rev Med Pharmacol Sci. 2015; 19: 3674-3681
17. European Commission. The eHealth Network Available at http://ec.europa.eu/health/ehealth/policy/index_en.htm. Accessed on 20 February 2017
18. Pederson N, Thielsen P, Martinsen L, Munkholm P, et al. eHealth: Individualization of Mesalazine treatment through a self-managed web-based solution in mild-to-moderate ulcerative colitis. Inflamm Bowel Dis. 2014; 20: 2276-2285
19. Long DM, Kappelman MD, Martin CF, et al. Development of an internet-based cohort of patients with inflammatory bowel disease (CCFA Partners): Methodology and initial results. Inflamm Bowel Dis. 2012; 18: 2099-2106
20. Aguas Peris M, Del Hoyo J, Bebia P, et al. Telemedicine in inflammatory bowel disease: opportunities and approaches. Inflamm Bowel Dis. 2015; 21: 392-9
21. Elkjaer M, Shuhaibar M, Burisch J, et al. E-Health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided ‘constant-care’ approach. Gut. 2010; 59: 1652-61
22. Stoyanov SR, Hides L, Kavanagh DJ, et al. Mobile app rating scale: A new tool for assessing the quality of health mobile apps. JMIR Health UHealth. 2015; 3(1): e27
23. LoPresti M, Abraham M, Appelboom G, et al. Clinical trials using mobile health applications. Pharm Med. 2015; 29(1): 17-25
24. Semple JL, Sharpe S, Murnaghan ML, et al. Using a mobie app for monitoring post-operative quality of recovery of patients at home: a feasibility study. JMIR MHealth UHealth. 2015; 3(1): e18
25. McCombie A, Langlotz T, Barclay M, et al. Systematic review of IBD smartphone apps for symptom monitoring and communication with healthcare professionals. Journal MHealth. 2016; 36-40
26. https://www.guthealthnetwork.com/tools-and-links/ibdsmart/
27. Dudley-Brown S. Correlates of uncertainty in inflammatory bowel disease. Dissertation abstracts international UMI no. 9604387. 1995
28. Thia K, Faubion WA Jr, Loftus EV Jr, Persson T, Persson A, Sandborn. Short CDAI: development and validation of a shortened and simplified Crohn’s disease activity index. Inflamm Bowel Dis. 2011; 17 (1): 105-11. doi: 10. 1002/ibd.21400
29. Harvey RF, Bradshaw JM. A simple index of Crohn’s disease activity. Lancet. 1980; 1: 514
30. McCombie A, et al. IBDSmartTM trial. HDEC 15/NTA/44. The Australian New Zealand Clinical Trials Registry. ACTRN12615000342516